Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print June 15, 2007
DOI: 10.2337/db07-0345

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-0345v1
56/9/2319    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dezaki, K.
Right arrow Articles by Yada, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dezaki, K.
Right arrow Articles by Yada, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Ghrelin employs G{alpha}i2 and activates Kv channels to attenuate glucose-induced Ca2+ signaling and insulin release in islet ß-cells: Novel signal transduction of ghrelin

Katsuya Dezaki1, Masafumi Kakei2, and Toshihiko Yada1

1Division of Integrative Physiology, Department of Physiology, Jichi Medical University School of Medicine, Yakushiji 3311-1, Shimotsuke, Tochigi 329-0498, Japan
2Department of Internal Medicine, Division of Endocrinology, Diabetes Geriatric Medicine, Akita University School of Medicine, Hondo 1-1-1, Akita 010-8543, Japan

Correspondence: tyada{at}jichi.ac.jp

Objective:Ghrelin reportedly serves as a physiological regulator of insulin release. This study aimed to explore signaling mechanisms for insulinostatic ghrelin action in islet ß-cells, with special attention to heterotrimeric GTP-binding proteins and K+ channels.

Research Design and Methods:Plasma insulin and growth hormone (GH) concentrations in rats were measured by ELISA. Islets were isolated from rats, ghrelin-knockout (Ghr-KO) and wild-type mice by collagenase digestion, and insulin release was determined by ELISA. In rat single ß-cells, cytosolic Ca2+ concentrations ([Ca2+]i) were measured by fura-2 microfluorometry, and membrane potentials and whole cell currents by patch-clamp technique.

Results:In rats, systemic ghrelin administration decreased plasma insulin concentrations and this effect was blocked by treatment with pertussis toxin (PTX), whereas stimulation of GH release remained unaffected. In rat islets, ghrelin receptor antagonist increased and exogenous ghrelin suppressed glucose-induced insulin release in a PTX-sensitive manner. Glucose-induced insulin release from islets was greater in Ghr-KO than wild-type mice, and this enhanced secretion was blunted with PTX. Ghrelin PTX-sensitively increased voltage-dependent K+ (Kv) currents without affecting ATP-sensitive K+ channels in rat ß-cells. In the presence of Kv channel blockers, ghrelin failed to suppress insulin release. Ghrelin attenuated glucose-induced action potentials and [Ca2+]i increases in ß-cells. Suppressions of [Ca2+]i increase and insulin release by ghrelin were blunted in ß-cells treated with PTX and with antisense oligonucleotide specific for G-protein G{alpha}i2 subunit.

Conclusions:Ghrelin attenuates glucose-induced insulin release via PTX-sensitive G{alpha}i2-mediated activation of Kv channels and suppression of [Ca2+]i in ß-cells, representing unique ghrelin's signaling distinct from that for GH release.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.